News
Article
Author(s):
As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in aesthetic/cosmetic dermatology this year.
Take a look at this overview of the top 5 considerations to show how CBP/β-catenin antagonists can be utilized for skin rejuvenation and anti-aging by enhancing Wnt/p300/β-catenin transcription.
Emmy Graber, MD, MBA, shared the truth behind cosmeceutical trends that patients may ask about from snail mucin to skin care refrigerators.
This data builds upon data of the READY-1 and READY-2 trials, wherein relabotulinumtoxinA's duration of effect was validated.
Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.
An investigation into skin changes at the cellular level provides insight into hyaluronic acid’s benefits.
Data on pigmentary disorders worldwide and clinical study results were presented at the IMCAS World Congress 2024 meeting.
The approval also marks the first and only approved HA dermal filler approved in the US for use in the upper face.
Amy B. Lewis, MD, explored the evolution of aesthetic dermatology, delving into injection sophistication, devices, and top procedures.
Moving the Needle on Ethics includes articles and interviews featuring experts in aesthetics.
Shah discussed the science behind his products, as well as the challenges he didn’t anticipate when launching Remedy.
In this study, topical 0.1% retinol significantly improved crow’s feet, facial wrinkles, uneven skin tone, brown spots, and overall photoaging.
The FDA released guidelines for clinicians and tips to identify the distinguishing features of counterfeit products.
While 84% of commercials targeted female consumers and 77% utilized celebrity influence, less than half mentioned specific ingredients in skin lightening products.
Renata Block, MMS, PA-C, shared her favorite topics from the aesthetic conference held last month.
These results are indicative of the need for dermatologists to discuss social media misinformation and low quality information with their patients.
The news of counterfeit Botox resulted in patients with blurred vision, difficulty swallowing, shortness of breath, and additional symptoms.
Researchers noted that many dermatologists face mild, non-life-threatening complications during procedures, yet must be prepared for emergencies.
A group of international experts focused on the technology’s potential to standardize and enhance patient assessments.
The new indication adds to existing clearances for hemostasis and electrocoagulation.
Omer Ibrahim, MD, discussed the nuances of aesthetic procedures for patients with skin of color and the importance of tailored treatments, safety, and improved clinician education.
Misleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.
Along with this new transparency regarding treatments, patients are empowered to embrace more comprehensive beauty ideals.
A study of a cleanser included diverse participants, ensuring it is suitable for various skin types and sensitivities.
Researchers noted that ethical use of AR and VR in cosmetic care requires balancing technological benefits with patient safety and privacy.
A review recognized the aesthetic concerns associated with GLP-1-induced weight loss and noted treatment options for various challenges.
Don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplements each month.